Metachronous carcinomas in colorectum and its clinicopathological significance

International Journal of Colorectal Disease

Volumn 27, Issue 10, 2012, Pages 1303-1310

  Lam, Alfred King Yin ^a   Gopalan, Vinod ^a   Carmichael, Robert ^b   Buettner, Petra Gertraud ^c   Leung, Melissa ^a   Smith, Robert ^a   Lu, Cu Tai ^d   Ho, Yik Hong ^c   Siu, Simon ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c JAMES COOK UNIVERSITY   (Australia)

^d GOLD COAST UNIVERSITY HOSPITAL   (Australia)

Author keywords

Cancer; Carcinoma; Colorectal; Metachronous; Multiple

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COHORT ANALYSIS; COLLOID CARCINOMA; COLORECTAL CARCINOMA; COLORECTAL METACHRONOUS CARCINOMA; COLORECTAL SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PREVALENCE; PRIMARY TUMOR; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; SURVIVAL ANALYSIS;

EID: 84866999907     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1474-y     Document Type: Article

References (23)

1. Bekdash B, Harris S, Broughton CI, Caffarey SM, Marks CG (1997) Outcome after multiple colorectal tumours. Br J Surg 84 (10):1442-1444
2. Chen HS, Sheen-Chen SM (2000) Synchronous and "early" metachronous colorectal adenocarcinoma: analysis of prognosis and current trends. Dis Colon Rectum 43(8):1093-1099
3. Wang HZ, Huang XF, Wang Y, Ji JF, Gu J (2004) Clinical features, diagnosis, treatment and prognosis of multiple primary colorectal carcinoma. World J Gastroenterol 10(14):2136-2139
4. Velayos FS, Lee SH, Qiu H, Dykes S, Yiu R, Terdiman JP, Garcia- Aguilar J (2005) The mechanism of microsatellite instability is different in synchronous and metachronous colorectal cancer. J Gastrointest Surg 9(3):329-335
5. Lan YT, Lin JK, Li AF, Lin TC, Chen WS, Jiang JK, Yang SH, Wang HS, Chang SC (2005) Metachronous colorectal cancer: necessity of post-operative colonoscopic surveillance. Int J Colorectal Dis 20(2):121-125
6. Park IJ, Yu CS, Kim HC, Jung YH, Han KR, Kim JC (2006) Metachronous colorectal cancer. Colorectal Dis 8(4):323-327
7. Ballesté B, Bessa X, Piñol V, Castellví-Bel S, Castells A, Alenda C, Paya A, Jover R, Xicola RM, Pons E, Llor X, Cordero C, Fernandez-Bañares F, de Castro L, Reñé JM, Andreu M, Gastrointestinal Oncology Group of the Spanish Gastroenterological Association (2007) Detection of metachronous neoplasms in colorectal cancer patients: identification of risk factors. Dis Colon Rectum 50(7):971-980
8. Yoon JW, Lee SH, Ahn BK, Baek SU (2008) Clinical characteristics of multiple primary colorectal cancers. Cancer Res Treat 40 (2):71-74
9. Tziris N, Dokmetzioglou J, Giannoulis K, Kesisoglou I, Sapalidis K, Kotidis E, Gambros O (2008) Synchronous and metachronous adenocarcinomas of the large intestine. Hippokratia 12(3):150-152
10. Hollington P, Tiong L, Young G (2011) Timing and detection of metachronous colorectal cancer. ANZ J Surg 81(4):272-274
11. Hamilton SR, Vogelstein B, Kudo S, Riboli E, Nakamura S, Hainaut P (2000) In: Hamilton SR, Aaltonen LA (eds) Carcinoma of the colon and rectum. WHO classification of tumors: pathology and genetics of tumors of digestive system. IARC Press, Lyon, pp 105-119
12. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96(4):261-268
13. Pritchard CC, Grady WM (2011) Colorectal cancer molecular biology moves into clinical practice. Gut 60(1):116-129
14. Geiersbach KB, Samowitz WS (2011) Microsatellite instability and colorectal cancer. Arch Pathol Lab Med 135(10):1269-1277
15. Lam AK, Carmichael R, Gertraud Buettner P, Gopalan V, Ho YH, Siu S (2011) Clinicopathological significance of synchronous carcinoma in colorectal cancer. Am J Surg 202(1):39-44
16. Lam AKY, Ong K, Ho YH (2006) Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 Expression. Dis Colon Rectum 49(9):175-183
17. Gopalan V, Smith RA, Ho YH, Lam AK (2011) Signet-ring cell carcinoma of colorectum-current perspectives and molecular biology. Int J Colorectal Dis 26(2):127-133
18. Leopoldo S, Lorena B, Cinzia A, Gabriella DC, Angela Luciana B, Renato C, Antonio M, Carlo S, Cristina P, Stefano C, Maurizio T, Luigi R, Cesare B (2008) Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological andgenetic features. Ann Surg Oncol 15(5):1429-39
19. Gopalan V, Smith RA, Nassiri MR, Yasuda K, Salajegheh A, Kim SY, Ho YH, Weinstein S, Tang JC, LamAK(2010) GAEC1 and colorectal cancer: a study of the relationships between a novel oncogene and clinicopathologic features. Hum Pathol 41(7):1009-1015
20. Lam AK, Ong K, Ho YH (2008) Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity. Hum Pathol 39 (4):599-604
21. Saleh S, Lam AK, Ho YH (2008) Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer. Pathology 40(1):25-30
22. Bülow S, Svendsen LB, Mellemgaard A (1990) Metachronous colorectal carcinoma. Br J Surg 77(5):502-505
23. Sargent DJ, Marsoni S, Monges G, Thibodeau SN, Labianca R, Hamilton SR, French AJ, Kabat B, Foster NR, Torri V, Ribic C, Grothey A, Moore M, Zaniboni A, Seitz JF, Sinicrope F, Gallinger S (2010) Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracilbased adjuvant therapy in colon cancer. J Clin Oncol 28(20):3219-3226